iRECIST-based versus non-standardized free text reporting of CT scans for monitoring metastatic renal cell carcinoma: a retrospective comparison.

Laura SchomburgAmer MalouhiMarc-Oliver GrimmMaja IngwersenSusan FollerKatharina LeuchtUlf K Teichgräber

Published in: Journal of cancer research and clinical oncology (2022)

Moderate agreement between disease response according to FTR or iRECIST in patients with mRCC suggests the need of standardized quantitative radiological assessment in daily clinical practice.

Keyphrases

metastatic renal cell carcinoma
clinical practice
computed tomography
dual energy
contrast enhanced
physical activity
high intensity
high resolution
adverse drug
positron emission tomography
magnetic resonance imaging
emergency department